Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Hoosier Cancer Research Network
AstraZeneca
University of Kentucky
Incyte Corporation
The Third Affiliated hospital of Zhejiang Chinese Medical University
Fundación GECP
Actuate Therapeutics Inc.
Masonic Cancer Center, University of Minnesota
Albert Einstein College of Medicine
Boston Scientific Corporation
Sun Yat-sen University
Second Affiliated Hospital, School of Medicine, Zhejiang University
MedImmune LLC
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Children's Hospital of Philadelphia
Barbara Ann Karmanos Cancer Institute
University of Southampton
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center